Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
230 USD | +1.29% | -0.86% | -0.69% |
12:51pm | Stifel Adjusts Price Target on IQVIA Holdings to $288 From $294 | MT |
05-03 | UBS Adjusts Price Target on IQVIA Holdings to $295 From $300, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.69% | 41.37B | |
+19.87% | 46.81B | |
+47.07% | 41.29B | |
-6.20% | 28.87B | |
+11.90% | 26.06B | |
-19.65% | 19.13B | |
+32.94% | 12.39B | |
+0.32% | 12.08B | |
+0.20% | 11.96B | |
+19.50% | 11.56B |
- Stock Market
- Equities
- IQV Stock
- News Iqvia Holdings Inc.
- Galera Therapeutics Sues Alira Health Clinical, IQVIA Biotech Over Alleged Error for Drug Trial